Abstract
Four A-type flavan-3-ol-dihydroretrochalcone dimers, dragonins A-D (1-4), were characterized from the traditional Chinese medicine Sanguis Draconis. The structures of 1-4 were elucidated by spectroscopic and spectrometric analyses. Compounds 1 and 2 exhibited significant inhibition of fMLP/CB-induced superoxide anion and elastase. The signaling pathways accounting for the inhibitory effects of compound 2 were also elucidated. These purified A-type flavan-3-ol-dihydroretrochalcones are new potential leads for the development of anti-inflammatory drugs.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Inflammatory Agents / chemistry
-
Anti-Inflammatory Agents / isolation & purification*
-
Anti-Inflammatory Agents / pharmacology*
-
Chalcones / chemistry
-
Chalcones / isolation & purification*
-
Chalcones / pharmacology*
-
Flavonoids / chemistry
-
Flavonoids / isolation & purification*
-
Flavonoids / pharmacology*
-
Humans
-
Molecular Structure
-
Neutrophils / drug effects
-
Nuclear Magnetic Resonance, Biomolecular
-
Pancreatic Elastase / antagonists & inhibitors
-
Resins, Plant / chemistry*
-
Superoxides / antagonists & inhibitors
Substances
-
Anti-Inflammatory Agents
-
Chalcones
-
Flavonoids
-
Resins, Plant
-
Superoxides
-
flavan-3-ol
-
Pancreatic Elastase